News from auxilium pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 22, 2014, 07:00 ET

Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease

Swedish Orphan Biovitrum AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for...

Dec 11, 2014, 17:05 ET

Auxilium Announces Date for Special Meeting of Stockholders

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that it has scheduled a special meeting of its stockholders for 8:30 a.m. ET on...

Nov 20, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced presentations of data from new studies,...

Nov 20, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Presents STENDRA Data At SMSNA Scientific Meeting

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data were presented...

Nov 19, 2014, 07:30 ET

Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals

Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the waiting period under...

Nov 03, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. to Present XIAFLEX and STENDRA Data at SMSNA Scientific Meeting

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data evaluating the use of...

Oct 30, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for...

Oct 20, 2014, 17:30 ET

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration...

Oct 09, 2014, 06:30 ET

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

 Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that they have entered into...

Sep 22, 2014, 07:00 ET

Auxilium Provides Transaction Update

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that its Board of Directors (the "Board") has...

Sep 18, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the first presentation of positive...

Sep 18, 2014, 06:00 ET

VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity

VIVUS, Inc. (Nasdaq: VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has...

Sep 17, 2014, 07:00 ET
Auxilium Offer Letter (PRNewsFoto/Auxilium Pharmaceuticals, Inc.)

Auxilium Responds To Unsolicited Proposal From Endo International

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today confirmed that Auxilium has received an...

Sep 09, 2014, 17:00 ET

Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced steps it is taking to reduce its costs...

Aug 28, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of...

Aug 27, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of...

Aug 21, 2014, 07:30 ET

Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced positive results from a randomized,...

Aug 11, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced that Andrew Saik will be...

Aug 07, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for...

Jul 31, 2014, 16:30 ET

Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that the Company will...